1,602
Views
4
CrossRef citations to date
0
Altmetric
Laboratory Study

Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression

, , , , , & ORCID Icon show all
Pages 869-877 | Received 29 Oct 2020, Accepted 09 Apr 2021, Published online: 17 May 2021

References

  • Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
  • Chen TH, Wen YH, Chen CF, et al. The advantages of peritoneal dialysis over hemodialysis during the COVID-19 pandemic. Semin Dial. 2020;33(5):369–371. 10.1111/sdi.12903.
  • Wang Z, Zhou Z, Ji W, et al. Silencing of lncRNA 6030408B16RIK prevents ultrafiltration failure in peritoneal dialysis via microRNA-326-3p-mediated WISP2 down-regulation. Biochem J. 2020;477(10):1907–1921.
  • Costalonga EC, Fanelli C, Garnica MR, Noronha IL. Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. Stem Cells Int. 2020;2020:1–11.
  • Li X, Liu H, Sun L, et al. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. J Cell Mol Med. 2019;23(4):2372–2383.
  • Wang Y, Shi Y, Tao M, Zhuang S, Liu N. Peritoneal fibrosis and epigenetic modulation. Perit Dial Int. 2021;41(2):168–178.
  • Chen YT, Chang YT, Pan SY, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.JASN. 2014;25(12):2847–2858.
  • Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515–524.
  • Guo Y, Wang L, Gou R, Tang L, Liu P. Noncoding RNAs in peritoneal fibrosis: background, mechanism, and therapeutic approach. Biomed Pharmacother. 2020;129:110385.
  • Kinashi H, Ito Y, Mizuno M, et al. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.JASN. 2013;24(10):1627–1642.
  • Loureiro J, Aguilera A, Selgas R, et al. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.JASN. 2011; 22(9):1682–1695.
  • Patel P, West-Mays J, Kolb M, et al. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol. 2010;29(2):97–106.
  • Wang L, Liu N, Xiong C, et al. Inhibition of EGF receptor blocks the development and progression of peritoneal fibrosis. JASN. 2016;27(9):2631–2644.
  • Shen N, Lin H, Wu T, et al. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis. Kidney Int. 2013;84(1):64–77.
  • Wen X, Liu A, Yu C, et al. Inhibiting post-translational core fucosylation prevents vascular calcification in the model of uremia. Int J Biochem Cell Bilo. 2016;79:69–79.
  • Venkatachalam MA, Weinberg JM. New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-β signaling. Kidney Int. 2013;84(1):11–14.
  • Li L, Shen N, Wang N, et al. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats. Kidney Int. 2018;93(6):1384–1396.
  • Nie J, Dou X, Hao W, et al. Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int. 2007;72(11):1336–1344.
  • Xie H, Fang M, Lin H, et al. Intermittent high-volume hemofiltration promotes remission in steroid-resistant idiopathic nephrotic syndrome. Ren Fail. 2015;37(6):966–973.
  • Lin H, Wang D, Wu T, et al. Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol. 2011;300(4):F1017–F1025.
  • Wang X, Gu J, Miyoshi E, Honke K, Taniguchi N. Phenotype changes of Fut8 knockout mouse: core fucosylation is crucial for the function of growth factor receptor(s). Methods Enzymol. 2006;417:11–22.
  • Mehta A, Herrera H, Block T. Glycosylation and liver cancer. Adv Cancer Res. 2015;126:257–279.
  • Zhang Y, Fan C, Zhang L, Ma X. Glycosylation-dependent antitumor therapeutic monoclonal antibodies. Prog Mol Biol Transl Sci. 2019;163:471–485.
  • Suradej B, Sookkhee S, Panyakaew J, et al. Kaempferia parviflora extract inhibits stat3 activation and interleukin-6 production in hela cervical cancer cells. IJMS. 2019;20(17):4226.
  • Zhang L, Zhang J, Chen Z, et al. Epidermal growth factor (EGF) triggers the malignancy of hemangioma cells via activation of NF-κB signals. Biomed Pharmacother. 2016;82:133–140.